Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis.

Tan, Ryan Ying Cong; Toh, Chee Keong; Takano, Angela

Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis.

Tan, Ryan Ying Cong; Toh, Chee Keong; Takano, Angela.

Afiliação

Tan RYC; Division of Medical Oncology, National Cancer Centre, Singapore. Electronic address: ryan.shea.tan.y.c@singhealth.com.sg.
Toh CK; Division of Medical Oncology, National Cancer Centre, Singapore.
Takano A; Department of Anatomic Pathology, Singapore General Hospital, Singapore.

J Thorac Oncol ; 12(7): e90-e91, 2017 07.

Article em En | MEDLINE | ID: mdl-28629544

Assuntos

Antineoplásicos Imunológicos/efeitos adversos; Miastenia Gravis/etiologia; Miosite/etiologia; Nivolumabe/efeitos adversos; Humanos; Masculino; Pessoa de Meia-Idade; Miastenia Gravis/patologia; Miosite/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Nivolumabe / Miastenia Gravis / Miosite Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google